I'm Calling It: NuScale Power Stock Is a Buy Before June 2

NuScale Power shares are down 22% year to date in 2026, even after a 40% rebound over the past two weeks, and investors are waiting for catalysts around its May 7 earnings report and June 2 RBC conference presentation. The article highlights ongoing net losses, uncertainty around project pipeline conversion, and management’s ability to reinforce the long-term SMR story tied to AI-driven electricity demand. Near-term impact is likely limited, but the events could influence sentiment around pipeline traction and funding needs.

Analysis

SMR is still being traded like a story stock, but the market is starting to price the gap between narrative optionality and operating proof. The near-term setup is asymmetrical because the stock has already rerated sharply off deeply oversold levels; that means any conference-driven optimism can extend the bounce, but a lack of concrete customer conversion will quickly expose how little fundamental support exists underneath the move.

The real second-order issue is capital structure, not technology. In pre-commercial infrastructure names, every month of delayed monetization increases the probability of a dilutive financing event or more expensive convertibility terms, so the June 2 communication window matters less for what it says about demand and more for whether it helps postpone capital raises by another quarter or two. If management leans into long-duration AI power demand without showing nearer-term contracting evidence, the market may interpret that as narrative substitution for execution.

The biggest beneficiary of renewed SMR enthusiasm is not SMR itself but the broader ecosystem: engineering contractors, grid interconnect, and nuclear fuel cycle names tend to absorb the “picks-and-shovels” premium when investors re-rate the theme. The hidden bearish implication is that if hyperscaler interest is real, incumbents and modular-adjacent competitors with existing permitting or balance-sheet capacity should capture the first economics, while SMR remains the call option further out the curve.

Consensus appears too focused on the long-term addressable market and not enough on the sequencing risk. The next 30-60 days are about whether the company can convert exploratory interest into signed commercial milestones; the next 6-12 months are about whether it can fund the gap without punitive dilution. That makes the setup tactically tradable but strategically fragile: upside on improved disclosure, downside if management’s pitch stays aspirational.

Key Decisions for Investors

• Trade SMR tactically only around event risk: buy a small starter position into the June 2 presentation and pair it with a tight risk stop if the event lacks customer or pipeline specificity; aim for a 10-15% pop on narrative follow-through, but cut quickly if the stock fades back below the post-squeeze range.
• Prefer a defined-risk call spread over outright stock in SMR for the next 4-8 weeks; the thesis is event-driven rerating, not fundamental de-risking, so upside can be captured while capping downside if management disappoints.
• Use weakness in SMR to build a relative-value long basket in nuclear/energy infrastructure beneficiaries versus SMR itself; the market is more likely to pay for nearer-term cash generation and permitting certainty than for pre-revenue optionality.
• If May/June communications emphasize liquidity and capital needs over contract wins, consider shorting SMR on any strength as a financing-risk trade; the reward/risk improves materially if the stock is priced for perfection after the recent rebound.